MAJOR HEADLINES OF STOCK MARKET - 18 APR 2017

MAJOR HEADLINES

• India plans stake sales worth $5.4 bn in 7 govt cos.
• TCS shareholders approve Rs16,000 cr share buyback.
• HC issues notice to govt on PIL against ITC stake.
• Tata Steel board to decide on fund raising this week.
• Economy to grow 7.2% in FY18; GST to have positive impact: World Bank.
• Note ban crimps MFIs' securitisation by 21% in FY17.
• L&T bags Rs2227 cr contracts in water & effluent treatment segment.
• IRDAI reduces third party insurance rates.
• Punj Lloyd overseas subsidiary wins Rs312 crore project in Saudi Arabia.
• Muthoot Capital board meets for results, bonus.
• FIPB clears Baxter Healthcare-Claris Injectibles deal worth Rs4,020 crore.
• Wholesale inflation falls to 5.7% in March from 6.5% in February.
• NDTV looks to sell assets.
• ISRO plans Joint Venture with industries for rocketbuilding.
• Govt makes Third party audit must for oil & gas licence extension.
• Warburg Pincus planning to sell 10% stake in Capital first.
• IMD to issue the First Long Range Forecast for 2017 southwest monsoon today.
• Jet Airways & Virgin Atlantic plans to expand code sharing for India – US flights.
• HPCL approves resumption of Rajasthan Refinery Project.
• Godrej Properties ties up with Taj to build luxury hotel.
• Tata Power says Mundra expansion plan on hold due to lack of demand.
• IndusInd Bank introduces portal for foreign exchange service.
• UBHL Winding Up Case: Karnataka HC gives ED time to respond to its notice.
• Aurobindo Pharma Gets US_FDA Nod For Rocuronium Bromide Injectable. Rocuronium Is A Muscle Relaxant Used In Modern Anaesthesia Presurgery.

Get real time advice for  Stock Trading tips , Best Accurate Stock Tips , Stock Market Live , Equity Tips  and all Maket Updates From Capitalstars  .

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647